《沪深两市》上证深成半日升1.2%-1.5% 创板重上三千点水平 券商、汽车股上扬
中国人民银行公开市场今日进行100亿元人民币(下同)7天期逆回购操作，另有100亿元逆回购到期；中标利率持平於2.2%。人民币兑美元中间价上调。人汇走强，上证深成高开後逐步回升，其後各指数升幅显着扩大，其中创板更升近3%。
上证半日升1.2%或41点，收报3,471点；深成升211点或1.5%，收报14,128点；沪深300指数升86点或1.7%，收报5,079点；创业板指数升70点或2.4%，收报3,014点，成交1,044亿元。沪深两市成交分别为2,331亿元及2,900亿元。
中资金融股窄幅走个别，工行(601398.SH)、建行(601939.SH)分别升0.2%及跌0.1%。中国平安(601318.SH)升2.1%。
券商股造好，湘财股份(600095.SH)、浙商证券(601878.SH)涨停。东方财富(300059.SZ)、国投资本(600061.SH)、中信证券(600030.SH)、国盛金控(002670.SZ)升4.4%-8.4%。
汽车股走强，长安汽车(000625.SZ)涨9.9%。北汽蓝谷(600733.SH)、东风汽车(600006.SH)、宇通客车(600066.SH)、广汽集团(601238.SH)升2%-3.7%。
钢铁股高开低走，鞍钢股份(000898.SZ)、重庆钢铁(601005.SH)、太钢不锈(000825.SZ)、八一钢铁(600581.SH)跌1.5%至1.8%。
环保工程股造好，中创环保(300056.SZ)、绿色动力(601330.SH)涨停。中环装备(300140.SZ)、维尔利(300190.SZ)、三峰环境(601827.SH)升3.2%-9.6%。
中医药股继续上扬，西藏药业(600211.SH)、神奇制药(600613.SH)、吉药控股(300108.SZ)、大理药业(603963.SH)涨停。同仁堂(600085.SH)、葫芦娃(605199.SH)、广誉远(600771.SH)升3.8%-6.9%。
贵州茅台(600519.SH)重上2,000元大关，股价半日升2.4%，造2,019元。(ta/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
